Clinical Trials Logo

Clinical Trial Summary

Ischemic strokes are a leading cause of death and disability worldwide. In 20% of cases they are caused by the rupture of atherosclerotic plaques in carotid arteries. Risk estimation of plaque rupture is currently suboptimal. Although pathology studies have shown that plaque composition provides a better risk assessment (lipid-rich core with thin fibrous cap = high risk (unstable plaque); fibrous core and a thick fibrous cap = low risk (stable plaque)), plaque composition cannot be determined using imaging techniques, and can therefore not be assessed non-invasively. Ultrasound, which is already widely used in clinical practice to determine plaque geometry could be an optimal technique to determine plaque composition and monitor plaques in a large population, due to its low patient burden, relatively low cost and speed of measurement. However, using conventional ultrasound it is not possible to reliably determine plaque composition. However, this might be possible using newly developed ultrasound functionalities(shear wave and strain elastography) enabling tissue stiffness estimation. It is known that recurrence risk is greatest in the first week after a stroke or transient ischemic attack (TIA) and decreases afterwards, probably due to a stabilization of the plaque due to a change in composition. Additionally, lipid-lowering medication is known to further reduce the recurrence risk after such an event, probably due to an acceleration of the stabilization process of the plaque. In this study, the investigators want to investigate whether Ultra-COMPASS ultrasound measurements (a combination of shear wave and strain elastography and ultrafast compounding (a fast variant of standard anatomical ultrasound to determine plaque geometry)) could be used to determine changes in plaque composition after a stroke / TIA. Primary objective: Investigate whether it is possible to detect plaque stabilization, determined by plaque stiffness, after a brain infarction or transient ischemic attack with Ultra-COMPASS ultrasound measurements. Secundary objectives: - Determine the association between (changes in) Ultra-COMPASS measurements and the lipid-lowering drugs used 6 and 12 weeks after ischemic stroke. - Determine the association between Ultra-COMPASS measurements and recurrent cardiovascular events (TIA / cerebral infarction / myocardial infarction/death) 6 and 12 weeks after ischemic stroke. - Determine the association between Ultra-COMPASS measurements and (changes in) low-density lipoprotein levels 6 and 12 weeks after ischemic stroke (if known). Study design: This is a prospective, longitudinal, observational, single-center cohort study in patients after a cerebral infarction or TIA with stenosis of one / both carotid arteries of 30-70% that receive or start withcholesterol-lowering medication. Ultra-COMPASS measurements will be taken within 7 days after brain infarction/TIA and at 6 ± 1 and after 12 ± 1 weeks in both carotid arteries to see if plaques stabilize overtime and to what extent medication stimulates a beneficial change in plaque composition.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT05029661
Study type Observational
Source Radboud University
Contact
Status Not yet recruiting
Phase
Start date September 1, 2021
Completion date January 1, 2023

See also
  Status Clinical Trial Phase
Completed NCT02224339 - New Technologies to Determine Carotid Plaque Vulnerability
Recruiting NCT04679727 - The Carotid Artery Multi-modality Imaging Prognostic (CAMP) Study
Recruiting NCT02476396 - Structural Stability of Carotid Plaque and Symptomatology
Completed NCT02947360 - The FOVUS-ER Study: Focused Vascular Ultrasound to Risk Stratify Patients With Chest Pain in the ER N/A
Active, not recruiting NCT03335033 - New Technologies to Determine Carotid Plaque Vulnerability in Patients With Significant Carotid Plaques Phase 2
Not yet recruiting NCT03072225 - Study on Vulnerable Plaque of Carotid Artery With Chinese Herbal and Insects Medicine Phase 2
Recruiting NCT03982420 - The ENROUTE Transcarotid Neuroprotection System (ENROUTE Transcarotid NPS) DW-MRI Evaluation
Terminated NCT02667457 - 99mTc-rhAnnexin V-128 Imaging for Carotid Atherosclerosis Phase 2
Not yet recruiting NCT04913493 - Use of Sublingual Microcirculation and FloTrac Monitoring During Major Vascular Surgery and Its Effect on Hospital LOS N/A
Recruiting NCT04470687 - Ultrafast Ultrasound Imaging Assesment of Carotid Plaque Neovascularization N/A
Not yet recruiting NCT04318171 - The Evaluation of Tomographic 3D Ultrasound for the Assessment of Vascular Pathology
Suspended NCT04063709 - Transcutaneous ARFI Ultrasound for Differentiating Carotid Plaque With High Stroke Risk N/A
Suspended NCT04835571 - CARotid Mri of Atherosclerosis N/A
Completed NCT01389388 - Effects of Rosuvastatin on Carotid Artery Plaques in Patients With Inflammatory Joint Disease N/A
Completed NCT02726984 - Carotid Plaque Assessment Using 18Fluorine (18F) -Sodium Fluoride Positron Emission Tomography (PET) /MR N/A
Completed NCT02820207 - Identification of Carotid Plague Vulnerability by Contrast Enhanced Ultrasound: Correlation With Plague Histopathology
Recruiting NCT03840265 - Evaluation of Cerebrovascular Events in Patients With Occlusive Carotid Artery Disorders N/A
Completed NCT03985774 - The ENROUTE Transcarotid Neuroprotection System (ENROUTE Transcarotid NPS) DW-MRI Study
Recruiting NCT04237064 - Photoacoustic Imaging of Atherosclerotic Plaques
Recruiting NCT03068442 - The Role of Large Artery Plaque Imaging Features in Predicting Inflammation and Cognition Phase 2